Literature DB >> 1773964

Wilson's disease in Scotland.

R H Park1, P McCabe, G S Fell, R I Russell.   

Abstract

The prevalence and clinical features of Wilson's disease in Scotland were investigated. Thirty three cases were identified but adequate information was available on only 28. In 1989, the prevalence rate was 4 per million. Ten patients with a mean (SEM) age of 18 (1.9) years presented with neurological symptoms, 12 patients aged 14 (1.7) years presented with hepatic symptoms, and six patients aged 12 (0.9) years were asymptomatic siblings of patients with Wilson's disease. Nine (56%) of the 16 patients who underwent liver biopsy on presentation were found to have cirrhosis. Penicillamine treatment was stopped in nine patients because of: abnormal peripheral blood count (6), rash (2), and patient's own choice (1). Nineteen patients were alive in 1989 -12 were well, one had chronic liver failure, four chronic neurological disabilities, and two had both chronic liver failure and neurological disabilities. Twelve patients died from: complications of chronic liver failure (2), acute liver failure (4), pneumonia associated with immobility (4), and other causes (2). Several patients who died had received incomplete medical supervision.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1773964      PMCID: PMC1379259          DOI: 10.1136/gut.32.12.1541

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Descriptive epidemiology of selected neurologic and myopathic disorders with particular reference to a survey in Rochester, Minnesota.

Authors:  L T KURLAND
Journal:  J Chronic Dis       Date:  1958-10

2.  Prevalence and occurrence of some rare neurological diseases in Iceland.

Authors:  K R Gudmundsson
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

3.  A genetic study of Wilson's disease: evidence for heterogeneity.

Authors:  D W Cox; F C Fraser; A Sass-Kortsak
Journal:  Am J Hum Genet       Date:  1972-11       Impact factor: 11.025

4.  Prevention of Wilson's disease in asymptomatic patients.

Authors:  I Sternlieb; I H Scheinberg
Journal:  N Engl J Med       Date:  1968-02-15       Impact factor: 91.245

5.  Wilson's disease in India. I. Geographic, genetic, and clinical aspects in 16 families.

Authors:  D K Dastur; D K Manghani; N H Wadia
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

6.  [The epidemiology of Wilson's disease in the German Democratic Republic and current problems from the viewpoint of population genetics].

Authors:  H Bachmann; J Lössner; B Gruss; U Ruchholtz
Journal:  Psychiatr Neurol Med Psychol (Leipz)       Date:  1979-07

7.  Wilson's disease.

Authors:  A W Downie
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

8.  A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration).

Authors:  A G BEARN
Journal:  Ann Hum Genet       Date:  1960-04       Impact factor: 1.670

9.  An assessment of efficiency in potential screening for Wilson's disease.

Authors:  T Saito
Journal:  J Epidemiol Community Health       Date:  1981-12       Impact factor: 3.710

10.  Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease.

Authors:  J Roche-Sicot; J P Benhamou
Journal:  Ann Intern Med       Date:  1977-03       Impact factor: 25.391

View more
  6 in total

1.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Authors:  Dorothy A Kieffer; Valentina Medici
Journal:  Liver Res       Date:  2017-08-16

Review 2.  Epidemiology, diagnosis, and treatment of Wilson's disease.

Authors:  Jing Liu; Jing Luan; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2017-11

3.  A genetic study of Wilson's disease in the United Kingdom.

Authors:  Alison J Coffey; Miranda Durkie; Stephen Hague; Kirsten McLay; Jennifer Emmerson; Christine Lo; Stefanie Klaffke; Christopher J Joyce; Anil Dhawan; Nedim Hadzic; Giorgina Mieli-Vergani; Richard Kirk; K Elizabeth Allen; David Nicholl; Siew Wong; William Griffiths; Sarah Smithson; Nicola Giffin; Ali Taha; Sally Connolly; Godfrey T Gillett; Stuart Tanner; Jim Bonham; Basil Sharrack; Aarno Palotie; Magnus Rattray; Ann Dalton; Oliver Bandmann
Journal:  Brain       Date:  2013-03-21       Impact factor: 13.501

Review 4.  Wilson's disease and other neurological copper disorders.

Authors:  Oliver Bandmann; Karl Heinz Weiss; Stephen G Kaler
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

5.  Epidemiology and natural history of Wilson's disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016.

Authors:  Ka-Shing Cheung; Wai-Kay Seto; James Fung; Lung-Yi Mak; Ching-Lung Lai; Man-Fung Yuen
Journal:  World J Gastroenterol       Date:  2017-11-21       Impact factor: 5.742

6.  The impact of Wilson disease on myocardial tissue and function: a cardiovascular magnetic resonance study.

Authors:  Janek Salatzki; Isabelle Mohr; Jannick Heins; Mert H Cerci; Andreas Ochs; Oliver Paul; Johannes Riffel; Florian André; Kristóf Hirschberg; Matthias Müller-Hennessen; Evangelos Giannitsis; Matthias G Friedrich; Uta Merle; Karl Heinz Weiss; Hugo A Katus; Marco Ochs
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-24       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.